|
Feb 29
|
Compass Pathways Plc (CMPS) Q4 2023 Earnings Call Transcript
|
|
Feb 29
|
Compass Pathways PLC Reports Increased Annual Net Loss Amid Clinical Advancements
|
|
Feb 29
|
Compass Pathways Announces Fourth Quarter 2023 Financial Results and Business Highlights
|
|
Feb 26
|
Compass Pathways to participate in upcoming TD Cowen investor conference
|
|
Feb 22
|
Compass Pathways to announce fourth quarter and year-end 2023 financial results on February 29, 2024
|
|
Feb 19
|
Wall Street Says Compass Pathways Could Rise 307%. Here's How It Could Actually Happen.
|
|
Jan 16
|
Compass Pathways enters into research collaboration agreement with Hackensack Meridian Health to develop optimal clinical model for investigational COMP360 psilocybin treatment, if FDA-approved
|
|
Jan 9
|
Therapy’s New Frontier: 3 Psychedelic Stocks for the Mental Health Revolution
|
|
Jan 8
|
3 Big New Catalysts for Psychedelics Stocks in 2024
|
|
Jan 5
|
Compass Pathways and Greenbrook TMS enter into three-year research collaboration agreement
|
|
Dec 19
|
Compass Pathways announces investigational COMP360 psilocybin treatment was well-tolerated in phase 2 study of post-traumatic stress disorder
|
|
Dec 13
|
25 Best Online Psychology Degree Programs Heading Into 2024
|
|
Dec 7
|
Compass Pathways appoints Teri Loxam as Chief Financial Officer
|
|
Dec 6
|
Study results of psilocybin treatment in bipolar II depression published in JAMA Psychiatry
|
|
Nov 5
|
COMPASS Pathways plc (NASDAQ:CMPS) Q3 2023 Earnings Call Transcript
|
|
Nov 3
|
Compass Pathways Plc (CMPS) Q3 2023 Earnings Call Transcript
|
|
Aug 26
|
3 Cathie Wood Stocks With Parabolic Growth Potential, According to Wall Street
|